---
title: Indo-MIM IPO - Should you apply in this issue? Here's in-depth information
url: https://dhan.co/blog/ipo/indo-mim-ipo-should-you-apply-in-this-issue/
page_type: blog_post
last_updated: 2026-07-23
---

# Indo MIM IPO Review - Apply or avoid?

Indo-MIM brings a globally dominant, profitable, and fast-growing precision engineering business to the public market.

### Key takeaways:

1. Indo-MIM is a Bengaluru-based precision engineering company and the world's largest MIM manufacturer, with a 6.8% global revenue share.
2. The IPO opens July 23 and closes July 27, 2026, with a price band of ₹461 to ₹485 per share.
3. Total issue size is ₹3,811 crore; ₹3,311 crore of this is OFS, meaning proceeds go to selling shareholders, not the company.
4. Fresh issue proceeds of ₹500 crore are primarily earmarked for debt repayment.
5. Revenue grew 25.93% in FY26; PAT stood at ₹5,335 million with an ROE of 21.26%.
6. Post-issue P/E is 44.95x, a premium valuation that warrants peer comparison.
7. Key risks include no long-term customer contracts, high import dependence, and promoter-related regulatory disclosures.

This week, one of the bigger-scaled mainboard IPOs of 2026 has been opened for subscribing. [Indo-MIM IPO](https://dhan.co/ipo/indomim-ipo/) is attracting both retail as well as institutional investors. With a ₹3,811 crore issue size, strong grey market premium, and a business built on precision engineering, there is a lot to unpack.

The information regarding IPO details, financials, strengths, and risk factors has been taken directly from the "Red Herring Prospectus (RHP)" that was submitted on 17th of July, 2026 to SEBI and is provided below for your own research before the public announcement of the IPO. Let's take a look at all of the facts.

## What does Indo-MIM do?

Indo-MIM Limited was incorporated in 1996 and has its headquarter in Hoskote, Bengaluru. It is the world's largest manufacturer of Metal Injection Moulding (MIM) precision engineering components by revenue and has occupied this rank for six years straight (Source: Frost and Sullivan Report cited in RHP) with a 6.8% market share.

Indo-MIM delivers the versatility of plastic injection moulding coupled with the strength and material attributes of metal. It is capable of creating complex, small, high-precision components in large numbers. Other than MIM, the company employs investment casting, ceramic injection moulding, precision machining and 3D metal printing (additive manufacturing) processes.

As of March 31, 2026, per the RHP:

1. During FY2026, a total of more than 9,000 varieties of products were produced.
2. Delivered services to 55 countries in the past three fiscal years.
3. Has 15 manufacturing operations: 6 in India, 6 in the US, 2 in the UK and 1 in Mexico.
4. It runs sales offices in China, Germany, and the United States.
5. Works with 13 sales representatives in Europe, Asia and the Middle East.

It provides service to automobile, defence, medical, consumer and aerospace sectors. Promoters include Green Meadows Investments Ltd. (Mauritius-based), Krishna Chivukula (Chairman and MD), Krishna Chivukula Jr. (CEO), Raj Chivukula, and Jagadamba Chandrasekhar.

## Indo-MIM IPO at a glance: Key dates and details

Here are the key dates, price band, lot size, and issue structure details for the Indo-MIM IPO at a quick glance.

| Parameter | Details |
| --- | --- |
| IPO open date | July 23, 2026 |
| IPO close date | July 27, 2026 |
| Anchor investor date | July 22, 2026 |
| Allotment date | July 28, 2026 |
| Listing date | July 30, 2026 (BSE and NSE) |
| Price band | ₹461 to ₹485 per share |
| Face value | ₹1 per share |
| Lot size | 30 shares |
| Minimum retail investment | ₹14,550 (upper price band) |
| Total issue size | ₹3,811.21 crore |
| Fresh issue | ₹500 crore (up to ₹5,000 million) |
| Offer for Sale (OFS) | 6,82,91,022 equity shares (~₹3,311 crore) |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Book running lead managers | HDFC Bank, Axis Capital, ICICI Securities, Kotak Mahindra Capital, SBI Capital Markets |

**Quota split:**50% for Qualified Institutional Buyers (QIBs), 35% for retail investors, 15% for Non-Institutional Investors (NIIs).

## Indo-MIM financials: Restated consolidated figures from the RHP

All figures below are sourced directly from the Restated Consolidated Financial Information in the RHP.

| Metric | FY2024 | FY2025 | FY2026 |
| --- | --- | --- | --- |
| Revenue from operations (₹ million) | 28,703.95 | 33,295.77 | 41,929.85 |
| Revenue growth (%) | 6.60% | 16.00% | 25.93% |
| EBITDA (₹ million) | 7,434.62 | 9,325.97 | 10,709.23 |
| EBITDA margin (%) | 25.90% | 28.01% | 25.54% |
| Profit After Tax (PAT) (₹ million) | 2,837.34 | 4,237.34 | 5,335.43 |
| PAT margin (%) | 9.88% | 12.73% | 12.72% |
| Basic EPS (₹) | 5.89 | 8.79 | 11.06 |
| Return on equity (%) | 14.01% | 19.94% | 21.26% |
| ROCE (%) | 19.59% | 23.51% | 26.60% |
| Debt-to-equity ratio | 0.53 | 0.57 | 0.39 |
| Net worth (₹ million) | 20,505.11 | 21,994.34 | 28,195.54 |
| Net asset value per share (₹) | 42.54 | 45.63 | 58.24 |

Revenue grew 25.93% in FY26. PAT rose from ₹4,237 million in FY25 to ₹5,335 million in FY26. Return ratios have improved consistently across all three years. One point to note: the EBITDA margin dipped from 28.01% in FY25 to 25.54% in FY26 even as revenue grew, which is worth monitoring post-listing.

## What happens to the IPO money?

The fresh issue proceeds of ₹500 crore will be used as follows per the RHP:

- ₹400 crore for repayment or prepayment of outstanding borrowings (including loans from HDFC Bank, Axis Bank, and Kotak Mahindra Bank, all of which are also Book Running Lead Managers {BRLMs} or BRLM affiliates.
- General corporate use (the maximum set at 25% of gross proceeds).

The OFS proceeds of approximately ₹3,311 crore go entirely to selling shareholders: Green Meadows Investments Ltd. (6,05,24,322 shares), Anuradha Koduri (54,59,000 shares), and IIT Madras (23,07,700 shares). None of these has a direct benefit to the company.

## IPO valuation

At the upper price band of ₹485, the post-issue P/E stands at approximately 44.95x based on FY26 diluted EPS of ₹10.87. The price-to-book ratio is approximately 10.63x based on the NAV per share of ₹58.24. These are top-quality multiples. The traders must take these figures into consideration, but only in relation to their peers from the same industry and listed firms in the precision engineering and speciality manufacturing sector.

## Strengths of Indo-MIM as a business

As outlined in the RHP:

### Innovative global leader in MIM

Largest manufacturer by revenue in the world for six consecutive years with 6.8% revenue market share in CY2025.

### Multi-geography manufacturing

15 locations in India, the US, the UK and Mexico mitigate global risk.

### Diversified revenue

Automotive contributed 24.61%, defence 18.69%, medical 18.08%, aerospace 11.96%, and consumer 10.80% in FY26.

### Export scale

77.20% of FY26 revenue came from outside India, across 55 countries.

### Improving return ratios

ROE improved from 14.01% in FY24 to 21.26% in FY26; ROCE rose from 19.59% to 26.60% over the same period.

### Strong operating cash flow

Net cash from operations was ₹10,772.41 million in FY26, nearly double the ₹5,062.71 million in FY25.

### Debt reduction

Total borrowings fell from ₹12,471.95 million in FY25 to ₹10,904.88 million in FY26.

## Risk factors investors should read carefully

The RHP lists the following as its top material risk factors:

### Customer concentration

Top 10 customers contributed 38.41% of FY26 revenue. Loss of one or two significant accounts could materially impact the business.

### Export dependence

77.20% of revenue came from outside India. Global macro slowdowns, trade restrictions, or geopolitical disruptions would directly impact the business.

### No long-term contracts

The business runs on purchase orders. Customers are not contractually bound to continue buying from Indo-MIM.

### Imported raw material risk

60.95% of total raw material purchases were imported in FY26, exposing the company to currency risk and supply disruptions.

### Manufacturing concentration

Indian facilities are clustered in one region, making them vulnerable to localised disruptions.

### Large OFS component

₹3,311 crore of the ₹3,811 crore issue is OFS. Proceeds go to selling shareholders, not the company.

### Conflict of interest in BRLMs

A portion of fresh issue proceeds will repay loans from HDFC Bank, Axis Bank, and Kotak Mahindra Bank, all of whom are BRLMs or BRLM affiliates.

### Pending litigations

Tax claims against the company total ₹4,212.52 million in aggregate.

### Regulatory risk on promoter

The name of Chairman and MD Krishna Chivukula appeared in the list of disqualified directors in the past, as disclosed in the RHP.

### Show cause notices

Promoters, directors, and KMPs have received notices for alleged non-compliance related to mandatory cost auditor appointment.

## How to apply for the Indo-MIM IPO?

Retail investors can apply via the ASBA facility or UPI-based applications through their broker. The UPI mandate must be submitted by 5:00 PM on July 27, 2026.

### Retail (RIB)

Minimum 1 lot (30 shares) = ₹14,550; maximum 13 lots (390 shares) = ₹1,89,150.

### Small NII

Minimum 14 lots (420 shares) = ₹2,03,700.

### Big NII

Minimum 69 lots (2,070 shares) = ₹10,03,950.

## Make an informed call on the Indo-MIM IPO

The RHP financials confirm consistent growth in revenue, PAT, and return ratios across three years.

The GMP signals strong near-term demand. However, the dominant OFS component, a 45x post-issue P/E, purchase order dependency, imported raw material exposure, and disclosed risks around promoter history and pending litigations are material factors. Review the full RHP, assess valuation relative to peers, and weigh your investment horizon carefully before applying.
